| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |